Johnson & Johnson 13F holdings
Johnson & Johnson reported 15 positions with a total reported value of $798.7M as of 2026-06-30, in its 13F for Q2 2026, filed 2026-08-06. Top holdings by reported value: PTGX PROTAGONIST THERAPEUTICS INC (37.6%), NBTX NANOBIOTIX (26.5%), MGTX MEIRAGTX HLDGS PLC (11.2%), RAPP RAPPORT THERAPEUTICS INC (9.3%), CTNM CONTINEUM THERAPEUTICS INC (4.1%). Against 2026-03-31 it opened 1 new position and exited 2. Next 13F due by 2026-11-14, the legal deadline 45 days after the quarter ending 2026-09-30.
Email me when Johnson & Johnson files its 13F
A free account follows up to 10 funds. New 13F filings arrive in your daily or weekly digest. No password and no card.
Top holdings
15 largest of 15 positions · reported value as of 2026-06-30
| Holding | Shares | Reported value | % of portfolio |
|---|---|---|---|
| PTGX PROTAGONIST THERAPEUTICS INC | 2,449,183 | $300.2M | 37.6% |
| NBTX NANOBIOTIX | 5,623,816 | $212.0M | 26.5% |
| MGTX MEIRAGTX HLDGS PLC | 6,641,064 | $89.7M | 11.2% |
| RAPP RAPPORT THERAPEUTICS INC | 1,784,517 | $74.4M | 9.3% |
| CTNM CONTINEUM THERAPEUTICS INC | 1,979,173 | $32.4M | 4.1% |
| LEGN LEGEND BIOTECH CORP | 814,586 | $23.5M | 2.9% |
| CVRX CVRX INC | 4,024,861 | $20.7M | 2.6% |
| XNCR XENCOR INC | 748,062 | $12.0M | 1.5% |
| CBRS CEREBRAS SYSTEMS INC | 53,586 | $11.8M | 1.5% |
| FATE FATE THERAPEUTICS INC | 3,379,064 | $9.1M | 1.1% |
| PRCT PROCEPT BIOROBOTICS CORP | 357,939 | $8.1M | 1.0% |
| NMRA NEUMORA THERAPEUTICS INC. | 1,849,445 | $3.1M | 0.4% |
| VOR VOR BIOPHARMA INC | 53,732 | $989.2K | 0.1% |
| LAB STANDARD BIOTOOLS INC | 311,967 | $256.7K | <0.1% |
| ACET ADICET BIO INC | 22,779 | $196.8K | <0.1% |
SEC FORM 13F · Q2 2026 · VALUES AS REPORTED, NOT PRICES
New positions this quarter
Held at 2026-06-30, not at 2026-03-31 · 1 in all · reported value as of 2026-06-30
| Holding | Shares | Reported value | % of portfolio |
|---|---|---|---|
| CBRS CEREBRAS SYSTEMS INC | 53,586 | $11.8M | 1.5% |
Sold out
Held at 2026-03-31, gone by 2026-06-30 · 2 in all · reported value as of 2026-03-31
Biggest increases and decreases
Positions held at both quarter ends, by change in shares · reported value as of 2026-06-30
Increases
No position was increased.
Decreases
No position was decreased.
CIK 200406 · 13F FILINGS ON EDGAR · INFORMATIONAL ONLY
